quinidine (redirected from Quinidine polygalacturonate)

quinidine /quin·i·dine/ (kwin´ĭ-dēn) the dextrorotatory isomer of quinine, used in the form of the gluconate, polygalacturonate, and sulfate salts in the treatment of cardiac arrhythmias; also used in the treatment of severe falciparum malaria.

---

quin·i·dine (kwn-dn)

n.

A colorless crystalline alkaloid that is a stereoisomer of quinine and is used as a treatment for malaria and cardiac arrhythmias.

---

quinidine

[kwin′ədēn, -din]

an antiarrhythmic agent administered as a bisulfate, gluconate, or polygalacturonate or as sulfate salts.

indications It is prescribed in the treatment of atrial flutter, atrial fibrillation, premature ventricular contractions, and tachycardias.

contraindications Known hypersensitivity to this drug prohibits its use. It is contraindicated in thrombocytopenia, myasthenia gravis, and some arrhythmias, particularly those associated with heart block.

adverse effects Among the most serious adverse effects are cardiac arrhythmia, hypertension, and cinchonism. Rare but potentially fatal hypersensitivity reactions such as anaphylaxis and thrombocytopenia may occur. Diarrhea, nausea, and vomiting are common.

---

quinidine [kwin´ĭ-dēn]

the dextrorotatory isomer of quinine, administered orally as the gluconate, polygalacturonate, or sulfate salts, or intravenously as the gluconate salt in treatment of cardiac arrhythmias. It is also administered intravenously as the gluconate salt in the treatment of life-threatening malaria caused by Plasmodium falciparum.

---

quinidine

the dextrorotatory isomer of quinine, used in treatment of cardiac arrhythmias. Several salts are used, including the gluconate, sulfate and bisulfate.

---

quinidine

Duraquin^®, Quinaglute^® Cardiology A class Ia antiarhythmic that ↓ myocardial excitability, conduction velocity, and contractility. See Therapeutic drug monitoring.